| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vestibulocochlear Nerve Diseases | D000160 | 1 associated lipids |
| Acromegaly | D000172 | 6 associated lipids |
| Actinobacillus Infections | D000189 | 4 associated lipids |
| Actinomycosis | D000196 | 2 associated lipids |
| Addison Disease | D000224 | 3 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mogi M and Kondo A | ELISA for RANKL-OPG complex in mouse sera. | 2010 | J Immunoassay Immunochem | pmid:20391022 |
| Schramm HM | The role of the osteoimmune axis in the inflammation of the inner auditory ear and with regard to the putative anticarcinogenetic principle: part 2. | 2010 | Inflamm Allergy Drug Targets | pmid:20402646 |
| Bartold PM et al. | Mechanisms and control of pathologic bone loss in periodontitis. | 2010 | Periodontol. 2000 | pmid:20403105 |
| Fanourakis G et al. | Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws. | 2010 | J. Oral Pathol. Med. | pmid:20701665 |
| Sanchez-Niño MD et al. | New paradigms in cell death in human diabetic nephropathy. | 2010 | Kidney Int. | pmid:20703212 |
| Le Heron L et al. | Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. | 2010 | J. Cyst. Fibros. | pmid:20005786 |
| Shead EF et al. | Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. | 2010 | J. Cyst. Fibros. | pmid:20006563 |
| Ostrowski MC | A new role for OPG: putting RANKL in its place. | 2010 | J. Bone Miner. Res. | pmid:20684024 |
| Qian H et al. | Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. | 2010 | J. Periodont. Res. | pmid:20412420 |
| Eagan TM et al. | Body composition and plasma levels of inflammatory biomarkers in COPD. | 2010 | Eur. Respir. J. | pmid:20413541 |
| Lamoureux F et al. | Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. | 2010 | Biochim. Biophys. Acta | pmid:19733222 |
| Mine Y et al. | Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. | 2010 | J Prosthodont Res | pmid:19733525 |
| Odiere MR et al. | Protein deficiency and nematode infection during pregnancy and lactation reduce maternal bone mineralization and neonatal linear growth in mice. | 2010 | J. Nutr. | pmid:20660285 |
| Saito-Yabe M et al. | PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver. | 2010 | J. Pharm. Pharmacol. | pmid:20663032 |
| Pantsulaia I et al. | Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. | 2010 | Osteoarthr. Cartil. | pmid:20633673 |
| Wagner H | Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis. | 2010 | Nat Rev Rheumatol | pmid:20125173 |
| Jiang XY et al. | Association of LPR5 polymorphism with bone mass density and cholesterol level in population of Chinese Han. | 2010 | Exp. Clin. Endocrinol. Diabetes | pmid:20146170 |
| Stankovic KM et al. | Differences in gene expression between the otic capsule and other bones. | 2010 | Hear. Res. | pmid:20146935 |
| Krause U et al. | Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20150512 |
| Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
| Sypniewska G et al. | Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? | 2010 | Med. Sci. Monit. | pmid:20110921 |
| Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
| Corallini F et al. | TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. | 2010 | Cell. Mol. Life Sci. | pmid:20063037 |
| Norazlina M et al. | Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. | 2010 | Med. J. Malaysia | pmid:21265240 |
| Kenanidis EI et al. | Serum levels of bone turnover markers following total joint arthroplasty. | 2010 | J Orthop Surg (Hong Kong) | pmid:21187538 |
| Wang X et al. | [Association of serum follicle stimulating hormone with osteoprotegerin, leptin, TGF-β1, and TGF-β2 in women]. | 2010 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:21200095 |
| Nabipour I et al. | Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. | 2009 Sep-Oct | Menopause | pmid:19387415 |
| Matsubara K et al. | Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. | 2009 Nov-Dec | J. Nephrol. | pmid:19967657 |
| Tuchendler D and Bolanowski M | [The role of osteoprotegerin and vitamin D in thyroid pathology]. | 2009 Nov-Dec | Endokrynol Pol | pmid:20041365 |
| GÅ‚uszko P | [Effects of biologic antirheumatic treatments on bone metabolism in rheumatoid arthritis and ankylosing spondylitis]. | 2009 Mar-Apr | Endokrynol Pol | pmid:19396755 |
| Doschak MR et al. | Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. | 2009 Mar-Apr | Mol. Pharm. | pmid:19718808 |
| Corallini F et al. | Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin. | 2009 Jan-Mar | Eur J Histochem | pmid:19351609 |
| Kolar P et al. | Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells. | 2009 Jan-Feb | Clin. Exp. Rheumatol. | pmid:19327236 |
| Nihrane A et al. | Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. | 2009 Jan-Feb | Blood Cells Mol. Dis. | pmid:19014892 |
| Koshikawa M et al. | Elevated osteopontin levels in patients with peripheral arterial disease. | 2009 Feb-Mar | Angiology | pmid:18388057 |
| Le XK et al. | Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. | 2009 Apr-Jun | Indian J Dent Res | pmid:19553712 |
| Miheller P et al. | Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. | 2009 | Inflamm. Bowel Dis. | pmid:19408329 |
| Chen BL et al. | [Effect of total flavone of Epimedium on expression of bone OPG, OPGL mRNA in ovariectomized rats]. | 2009 | Zhongguo Gu Shang | pmid:19408755 |
| O'Connor RD et al. | Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. | 2009 | Bone | pmid:19414073 |
| Han X et al. | Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. | 2009 | Oral Microbiol. Immunol. | pmid:19416447 |
| Corallini F et al. | The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis. | 2009 | Rheumatology (Oxford) | pmid:19168833 |
| Doumouchtsis K et al. | Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. | 2009 | Ther Apher Dial | pmid:19379170 |
| Sato MM et al. | Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. | 2009 | Genes Cells | pmid:19170762 |
| Jørgensen GM et al. | Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity. | 2009 | Eur. J. Endocrinol. | pmid:19380455 |
| Fili S et al. | Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors. | 2009 | Cancer Lett. | pmid:19201081 |
| Callaci JJ et al. | Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. | 2009 | Calcif. Tissue Int. | pmid:19330277 |
| Wada Y et al. | Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts. | 2009 | Arch. Oral Biol. | pmid:19201394 |
| Briana DD et al. | Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. | 2009 | Neonatology | pmid:19365143 |
| Wang AY | Vascular and other tissue calcification in peritoneal dialysis patients. | 2009 | Perit Dial Int | pmid:19270239 |
| Honsawek S et al. | Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. | 2009 | Pediatr. Surg. Int. | pmid:19184056 |
| Elders RC et al. | Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | 2009 | Vet. Immunol. Immunopathol. | pmid:19185923 |
| Duarte PM et al. | Effect of anti-infective mechanical therapy on clinical parameters and cytokine levels in human peri-implant diseases. | 2009 | J. Periodontol. | pmid:19186963 |
| Kobayashi Y et al. | Action of RANKL and OPG for osteoclastogenesis. | 2009 | Crit. Rev. Eukaryot. Gene Expr. | pmid:19191757 |
| Zhou Y et al. | The role of estrogen in osteogenetic cytokine expression in human periodontal ligament cells. | 2009 | Int J Periodontics Restorative Dent | pmid:19888494 |
| Zhang Y et al. | Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet. | 2009 | Bone | pmid:18848653 |
| Rashid G et al. | Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C. | 2009 | Am. J. Physiol. Renal Physiol. | pmid:18945829 |
| Andrade I et al. | CCR5 down-regulates osteoclast function in orthodontic tooth movement. | 2009 | J. Dent. Res. | pmid:19828893 |
| Li Y and Tang L | Local delivery of osteoprotegerin may be a way of reinforcing orthodontic anchorage. | 2009 | Med. Hypotheses | pmid:18951727 |
| Secchiero P et al. | Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye. | 2009 | J. Cell. Physiol. | pmid:18780288 |
| Klejna K et al. | OPG/RANK/RANKL signaling system and its significance in nephrology. | 2009 | Folia Histochem. Cytobiol. | pmid:19995704 |
| Crespi R et al. | Magnesium-enriched hydroxyapatite versus autologous bone in maxillary sinus grafting: combining histomorphometry with osteoblast gene expression profiles ex vivo. | 2009 | J. Periodontol. | pmid:19335078 |
| Suh KS et al. | Kaempferol attenuates 2-deoxy-d-ribose-induced oxidative cell damage in MC3T3-E1 osteoblastic cells. | 2009 | Biol. Pharm. Bull. | pmid:19336918 |
| Stolina M et al. | RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies. | 2009 | Arthritis Res. Ther. | pmid:20003323 |
| Shimizu M et al. | Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women. | 2009 | Horm. Res. | pmid:19339793 |
| Sziklai I et al. | Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss. | 2009 | Eur Arch Otorhinolaryngol | pmid:19340443 |
| Yuksel S et al. | Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. | 2009 | Tohoku J. Exp. Med. | pmid:19346738 |
| D'Amelio P et al. | The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. | 2009 | J. Endocrinol. Invest. | pmid:19724159 |
| Blackwell KA et al. | Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. | 2009 | Prostaglandins Other Lipid Mediat. | pmid:19744575 |
| Grundt A et al. | Direct effects of osteoprotegerin on human bone cell metabolism. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19748486 |
| Kwan Tat S et al. | Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. | 2009 | Rheumatology (Oxford) | pmid:19762475 |
| Rendina D et al. | Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases. | 2009 | Calcif. Tissue Int. | pmid:19763378 |
| Kim HN et al. | Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. | 2009 | Eur. J. Pharmacol. | pmid:19766111 |
| Graham LS et al. | Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. | 2009 | Clin. Immunol. | pmid:19699688 |
| Schwartz Z et al. | Osteoprotegerin (OPG) production by cells in the osteoblast lineage is regulated by pulsed electromagnetic fields in cultures grown on calcium phosphate substrates. | 2009 | Ann Biomed Eng | pmid:19139991 |
| Lamoureux F et al. | Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. | 2009 | Cancer Res. | pmid:19147566 |
| Liu J et al. | Pressure-loaded MSCs during early osteodifferentiation promote osteoclastogenesis by increase of RANKL/OPG ratio. | 2009 | Ann Biomed Eng | pmid:19148752 |
| Kusumi A et al. | Passage-affected competitive regulation of osteoprotegerin synthesis and the receptor activator of nuclear factor-kappaB ligand mRNA expression in normal human osteoblasts stimulated by the application of cyclic tensile strain. | 2009 | J. Bone Miner. Metab. | pmid:19449178 |
| Tang X and Meng H | Osteogenic induction and 1,25-dihydroxyvitamin D3 oppositely regulate the proliferation and expression of RANKL and the vitamin D receptor of human periodontal ligament cells. | 2009 | Arch. Oral Biol. | pmid:19464673 |
| Luckhaus C et al. | Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. | 2009 | J Neural Transm | pmid:19468818 |
| Sigrist MK et al. | Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. | 2009 | Nephrol. Dial. Transplant. | pmid:19491380 |
| Mikami S et al. | Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. | 2009 | J. Pathol. | pmid:19455604 |
| Dong SS et al. | Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. | 2009 | Calcif. Tissue Int. | pmid:19458885 |
| Teixeira L et al. | NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. | 2009 | J. Cell. Biochem. | pmid:19459152 |
| Ueland T et al. | A cohort study of the effects of serum osteoprotegerin and osteoprotegerin gene polymorphisms on cardiovascular mortality in elderly women. | 2009 | Clin. Endocrinol. (Oxf) | pmid:19508593 |
| Brennan TC et al. | Osteoblasts play key roles in the mechanisms of action of strontium ranelate. | 2009 | Br. J. Pharmacol. | pmid:19563530 |
| Lu TY et al. | DNA methylation and histone modification regulate silencing of OPG during tumor progression. | 2009 | J. Cell. Biochem. | pmid:19565568 |
| Chuang FH et al. | Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma. | 2009 | J. Oral Pathol. Med. | pmid:19566744 |
| Musacchio E et al. | The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells. | 2009 | J. Rheumatol. | pmid:19567627 |
| Tang TH et al. | Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid. | 2009 | J. Clin. Periodontol. | pmid:19570104 |
| Hofsø D et al. | Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. | 2009 | Eur. J. Endocrinol. | pmid:19542241 |
| Hu H et al. | Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. | 2009 | Transplantation | pmid:19543058 |
| Kim JG et al. | Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women. | 2009 | J. Korean Med. Sci. | pmid:19543507 |
| Rachner TD et al. | Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis. | 2009 | J. Cell. Biochem. | pmid:19544400 |
| Wang J et al. | [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients]. | 2009 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:19662974 |
| Zhang T et al. | The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. | 2009 | Biomaterials | pmid:19665222 |
| Polyzos SA et al. | The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone. | 2009 | Horm. Metab. Res. | pmid:19670154 |
| Buduneli N et al. | Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. | 2009 | J. Periodontol. | pmid:19656027 |
| Lee HJ et al. | Effects of nicotine on antioxidant defense enzymes and RANKL expression in human periodontal ligament cells. | 2009 | J. Periodontol. | pmid:19656028 |
| Lu X et al. | ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. | 2009 | Genes Dev. | pmid:19608765 |
| Talmor-Barkan Y et al. | Low extracellular Ca2+: a mediator of endothelial inflammation. | 2009 | Nephrol. Dial. Transplant. | pmid:19617602 |